InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,575.60
(
0.90%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.28
(
0.18%
)
Bitcoin
63,137.35
(
-1.35%
)
Post# of 1109
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Golden Cross

Send PM Follow Ignore
Followers 3345
Posts 84546
Boards Moderated 7
Alias Born 10/05/2005

Golden Cross

Member Level

Re: None

Saturday, 03/07/2020 11:39:51 AM

Saturday, March 07, 2020 11:39:51 AM

Post# of 1109
$ZSAN On March 4, 2020 , Zosano Pharma Corporation (the "Company") announced that the U.S. Food and Drug Administration (the "FDA") accepted the Company's New Drug Application (the "NDA") for Qtrypta for filing and substantive review.
$ZSAN On March 4, 2020 , the Company delivered notice of termination of the Sales Agreement to BTIG because it does not intend to raise additional capital through the ATM, and no additional shares of the Company's common stock will be sold pursuant to the Sales Agreement.

Give Me A Follow If You Want To Consistently Find Winners!

Click Here:
https://investorshub.advfn.com/boards/profilea.aspx?user=61470

Please do your own DD...All my posts are my opinion only!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up